Product Images Paclitaxel

This is a medical statistic report on the proportion of surviving patients. The main data is shown in the "Proportion Surviving" column indicating a value of 0.4. The text also shows two values under the "Number at Risk" section, which might represent the number of patients at risk of mortality, but the information is not enough to determine it accurately. The characters in the text are not in English, but they seem to be part of a table or a graph that shows different readings across several years.*

This appears to be a survival analysis table, that shows the proportion of individuals free from a disease over time. The table shows the hazard ratio (HR) of 0.92 and the 95% confidence interval (CI) from 0.5 to 0.73118. The table also displays the number of individuals at risk at different time points.*

This is a medical report that contains information about the proportion of individuals who are disease-free. There are also numerical values that might be related to the outcomes of a clinical trial or experiment. The values are as follows: 95% disease-free (with a confidence interval of 0.67 to 1.01), and two number at risk values recorded under AT and L. Additionally, there are numbers representing years.*

This text represents a chart that shows the proportion of individuals free of disease over the course of 4 years. The chart includes data for two treatment groups: AC+T and AC. The number of individuals at risk for each group is also shown. The confidence interval for the proportion of disease-free individuals is 95%.*

This is a description of Paclitaxel Injection, USP which is a Cytotoxic Agent. This requires dilution before Intravenous Infusion. The pack contains 5 mL Multi-Dose Vial which is sterile and protected from light. This product is manufactured in India and distributed by Athenex, based in Schaumburg, IL 60173 (USA). The product is only available with a prescription. The text includes information about the amount of Paclitaxel and Polyoxyl in each mL. There is space provided for batch details.*

Batch details for a product that appears to be a drug with the code AP/DRUGS/03/2011 made for Athenex, with a registered trademark from Novaplus company situated in Schaumburg, IL, USA. The batch details have a size of 27 x 12 mm, code 00-680420-8Y1Sd, and NDC70860-215-67 prior to intravenous infusion. Any other details are not available.*